|
|
 |
 |
| Proteins Congress 2010 is administered by Osney Media. |
|
|
|
|
 Speakers |
|
|
|
Our carefully researched speaker programmes are further enhanced by the opportunity for the delegates and speakers to discuss topics of interest in more detail during panel and round table discussions. This means that the attendees not only benefit from the expertise of the high level speaker panel but also that of the other delgates.
If you have a cutting edge case study or a presentation and would like to join the speaker panel at one of our events, please contact Mike Burden at m.burden@oxfordglobal.co.uk
The conference agenda was formulated with the help of an advisory panel which consisted of the experts below.
The 2009 Advisory Panel includes:
· Chris Gregory, CSO, Immnosol
· Ciarán N. Cronin, Head Parallel Protein Production Group, Pfizer Global Research & Development, San Diego
· Stephen Irving, Senior Principle Scientist, Structural Biology and Biophysics, Pfizer
· Judit Nagy, Proteomics Facility Director, Institute of Biomedical Engineering, Imperial College London
· David Szymkowski, Senior Director, Biotherapeutics, Xencor
· Peter Buckel, Chief Executive Officer, Suppremol GmbH, Germany
· Michael Dyson, Senior Research Associate, Department of Biochemistry, Univeristy of Cambridge
· Karol Kozak, Database Implememtation, High Content Screening; RISC, Eth Zurich
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Alexandra Alderton, Primary Pharmacology Group, Pfizer
|
|
|
|
Simon Brack, Head of Lead Discovery, Covagen AG
|
|
|
|
Rolf Brekken, Assistant Professor of Surgery and Pharmacology, UT Southwestern Medical Center, Dallas
|
|
|
|
Nicola Burgess Brown, Head of Biotechnology, Oxford, The Structural Genomics Consortium
|
|
|
|
Paul Carter, Investigator, GSK
|
|
|
|
Naomi Chayen, President of the International Organisation for Biological Crystallization, Department of BioMolecular Medicine, SORA Division, Faculty of Medicine, Imperial College London
|
|
|
|
Giuseppe Ciaramella, Executive Director Head of Biotherapeutics, Sandwich, Pfizer
|
|
|
|
Jeff Culp, Associate Research Fellow, Primary Pharmacology Group, Pfizer Global Research & Development
|
|
|
|
Michael Dyson, Senior Research Associate, Department of Biochemistry, University of Cambridge
|
|
|
|
Michael Feldhaus, Senior Director of Antibody Engineering, Adimab
|
|
|
|
Joachim Feldwisch, Project Manager, Affibody AB
|
|
|
|
Gianpaolo Fogliatto, Senior Scientist, Project Leader, Nerviano Medical Sciences
|
|
|
|
Robert Hayes, Venture Leader, Centyrex, Johnson & Johnson Ventures
|
|
|
|
Christian Heinis, Group Head, Laboratory of Therapeutic Peptides and Proteins, Ecole Polytechnique Federal de Lausanne (EPFL)
|
|
|
|
Syd Johnson, VP, Antibody Engineering, Macrogenics
|
|
|
|
John Liddell, Head of Process Science, Avecia Biologics
|
|
|
|
Tomas Lundqvist, Director Cell Protein and Structural Sciences (CPSS) DECS, AstraZeneca
|
|
|
|
Felix Oehme, Biotech Development, Bayer Schering Pharma AG
|
|
|
|
Sigurd Okkels, Vice President, Biologics Department, Discovery and Proof of Concept Development, Nycomed GmbH
|
|
|
|
Matthias Peipp, Section of Stem Cell Transplantation and Immunotherapy, Christian Albrechts University
|
|
|
|
Sřren K. Rasmussen, Senior Scientist, Antibody Expression, Symphogen A/S
|
|
|
|
Pier Giorgio Righetti, Professor, Department of Chemistry, Materials and Chemical Engineering, Politecnico di Milano
|
|
|
|
Diego Rodirguez Cabaleiro, Biopharmaceutical Business Development Manager, Chemistry Operations, Waters European Headquarters, Guyancourt, France
|
|
|
|
Aaron Sato, Senior Director of Antibody Engineering, OncoMed Pharmaceuticals
|
|
|
|
Arne Skerra, Professor of Biological Chemistry, Technische Universitaet Muenchen, Freising-Weihenstephan, Germany
|
|
|
|
Peter Sondermann, CSO, SuppreMol GmbH
|
|
|
|
Klaus Strein, Head Pharmaceutical Research, Penzberg (Germany), F. Hoffmann-La Roche
|
|
|
|
Dominic Tisi, Senior Scientist, Astex Therapeutics
|
|
|
|
David Urech, Head of R&D, ESBA Tech
|
|
|
|
Barbara Valsasina, Senior Scientist, Biology Dpt, Nerviano Medical Sciences
|
|
|
|
Paul Watt, Vice President Drug Discovery, Phylogica
|
|
|
|
Ulrich Wendt, Director of Structural Biology, Sanofi Aventis
|
|
|
|
Trevor Wilkinson, Head of Protein Sciences, MedImmune
|
|
|
|
Yuan Xu, Global Head/VP of Process Sciences, Production & Quality, Novartis Biologics
|
|
|
|
|
|
|
|
|
|
|
